Additional information
| Therapeutic Segment | Anti-diabetic |
|---|---|
| Dosage Form | Tablets |
| Specialities | Diabetologist, Physician |
Glimepiride 4 mg & Metformin PR 1000 mg Tablets are a combination antidiabetic therapy used to manage type 2 diabetes mellitus. The formulation combines immediate-release Glimepiride for prompt insulin stimulation and prolonged-release Metformin for extended glucose-lowering effect, helping maintain steady blood sugar levels throughout the day.
- Provides effective glycemic control in type 2 diabetes
- Glimepiride stimulates insulin secretion for rapid postprandial glucose reduction
- Metformin PR improves insulin sensitivity and reduces hepatic glucose production
- Prolonged-release formulation ensures steady blood sugar control with once or twice daily dosing
- Helps reduce the risk of diabetes-related complications when combined with diet and exercise
Take this medicine in the dose and duration as advised by your doctor. Swallow the tablet whole with water, preferably with meals to reduce gastrointestinal side effects. Do not crush or chew, as the prolonged-release Metformin layer is designed for extended action.
Glimepiride+Metformin is a combination of two medicines: Glimepiride and Metformin. This medicine is used in the treatment of type 2 diabetes mellitus (DM). It improves blood glucose levels in adults when taken along with proper diet and regular exercise.
Glimepiride lowers the blood glucose levels by increasing the release of insulin from the pancreas. Metformin works by lowering the glucose production in the liver and improving insulin sensitivity. This combination is not indicated for the treatment of type 1 DM
As directed by physician
